Beyond Standardization: Reimagining Clinical Pathways for a More Personalized Future
Clinical pathways have long occupied a unique place in health care. Designed to reduce unwarranted variation, improve quality, and support more efficient care delivery, pathways have evolved alongside advances in medicine, payment reform, and technology. In addition to serving as tools for reducing unnecessary variation care, they should also be designed to identify appropriate variation care that maximizes the opportunity for identifying the right treatment for the right patient at the right time. As health care becomes increasingly complex, the question is no longer whether pathways matter—it is how they must adapt to remain relevant.
This issue of the Journal of Clinical Pathways examines that question from several important viewpoints.
In our featured Perspectives article, Andrew Norden, MD, MBA, MPH, explores the growing disconnect between the original goals of oncology pathways and the realities of their implementation. While pathway programs have become widespread across health plans and integrated delivery systems, Dr Norden argues that payer-led models often struggle to keep pace with rapidly evolving cancer treatment, including the expanding role of biomarker-driven therapies and increasingly complex treatment regimens. His analysis highlights the challenges clinicians face when navigating multiple pathway programs and suggests a more sustainable future grounded in continuously updated evidence-based guidelines and targeted utilization management strategies.
The need for pathways to evolve is also the focus of this issue's Transformative Business Trends column. F. Randy Vogenberg, PhD, FASHP, examines how artificial intelligence (AI) is reshaping health care operations and decision-making. The column explores how advanced analytics, real-world evidence, and individualized data models may support more precise clinical decision-making while helping organizations meet quality and financial objectives. As AI capabilities continue to mature, their integration into pathway design may fundamentally change how care is delivered, measured, and managed.
Finally, this issue highlights the critical role of multidisciplinary care teams in advancing pathway-based oncology care. In an interview, Kishen Patel, PharmD, revisits findings from his award-winning abstract presented at last year’s Clinical Pathways Congress on pharmacist-driven outcomes for patients receiving oral oncology therapies. Dr Patel shares how integrated specialty pharmacy models can improve medication adherence, enhance patient engagement, proactively manage treatment-related adverse effects, and strengthen care coordination. His insights demonstrate how pathway success increasingly depends not only on treatment selection but also on the systems and professionals that support patients throughout their care journey.
Collectively, the articles in this issue illustrate how clinical pathways are evolving beyond their traditional role as tools for standardization. They are increasingly being used to balance innovation, personalization, and value. As health care continues to advance at a rapid pace, these perspectives offer important insights into how pathway programs can adapt to support better outcomes for patients while meeting the needs of clinicians, health systems, payers, and employers alike.
